6.25

1.46% 0.09

Kezar Life Sciences Inc (KZR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$6.16

Offen:

$6.15

24-Stunden-Volumen:

32,250

Relative Volume:

0.20

Marktkapitalisierung:

$45.11M

Einnahmen:

$7.00M

Nettoeinkommen (Verlust:

$-70.79M

KGV:

-0.645

EPS:

-9.69

Netto-Cashflow:

$-64.34M

1W Leistung:

+1.13%

1M Leistung:

+0.32%

6M Leistung:

+55.86%

1J Leistung:

-17.98%

1-Tages-Spanne:

$6.10

$6.25

1-Wochen-Bereich:

$6.10

$6.29

52-Wochen-Spanne:

$3.5334

$7.61

Kezar Life Sciences Inc Stock (KZR) Company Profile

Firmenname

Kezar Life Sciences Inc

Sektor

Healthcare (1129)

Branche

Biotechnology (632)

Telefon

650-822-5600

Adresse

4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA

Mitarbeiter

Twitter

@kezarbio

Nächster Verdiensttermin

2024-11-13

Neueste SEC-Einreichungen

KZR's Discussions on Twitter

Vergleichen Sie KZR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KZR Kezar Life Sciences Inc	6.25	45.11M	7.00M	-70.79M	-64.34M	-9.69
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-17	Herabstufung	Jefferies	Buy → Hold
2025-10-17	Herabstufung	William Blair	Outperform → Mkt Perform
2023-08-11	Herabstufung	Wells Fargo	Overweight → Equal Weight
2023-03-16	Herabstufung	William Blair	Outperform → Mkt Perform
2021-12-08	Eingeleitet	Wells Fargo	Overweight
2018-07-16	Eingeleitet	Jefferies	Buy
2018-07-16	Eingeleitet	Wells Fargo	Outperform
2018-07-16	Eingeleitet	William Blair	Outperform

Alle ansehen

Kezar Life Sciences Inc Aktie (KZR) Neueste Nachrichten

Nov 19, 2025

How institutional buying supports Kezar Life Sciences Inc. stockJuly 2025 Volume & Fast Moving Market Watchlists - newser.com

Nov 19, 2025

How supply chain issues affect Kezar Life Sciences Inc. stockJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - newser.com

Nov 19, 2025

Can Kezar Life Sciences Inc. (2KZ0) stock beat analyst consensusPortfolio Return Report & Precise Trade Entry Recommendations - newser.com

Nov 19, 2025

What valuation multiples suggest for Kezar Life Sciences Inc. stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 19, 2025

Top chart patterns to watch in Kezar Life Sciences Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com

Nov 19, 2025

Is Kezar Life Sciences Inc. stock a safe haven assetSwing Trade & Reliable Volume Spike Trade Alerts - newser.com

Nov 19, 2025

Visual trend scoring systems applied to Kezar Life Sciences Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com

Nov 19, 2025

Is Kezar Life Sciences Inc. (2KZ0) stock a buy for dividend portfoliosMarket Weekly Review & Weekly High Conviction Ideas - newser.com

Nov 19, 2025

Is Kezar Life Sciences Inc. (2KZ0) stock ideal for retirement investorsTreasury Yields & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025

How Kezar Life Sciences Inc. stock compares to industry benchmarksJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com

Nov 19, 2025

Will Kezar Life Sciences Inc. (2KZ0) stock attract long term capital inflows - newser.com

Nov 19, 2025

Nov 18, 2025

Will Kezar Life Sciences Inc. stock continue upward momentumWeekly Trade Summary & Low Drawdown Investment Strategies - newser.com

Nov 18, 2025

Kezar Life Sciences Initiates Major Overhaul Following Regulatory Setback - Ad-hoc-news.de

Nov 18, 2025

Equities Analysts Set Expectations for KZR FY2025 Earnings - Defense World

Nov 18, 2025